US Stocks
US Options
Emerging Asia
GBP Cash Savings
Charts & Tools
Paper Trading
Extended Hours
Wall Street Journal
TradingViewD
DXR
DAXOR CORP
12.85
0.000.00%Closed15:01 12/05 EST
OPEN/PREV CLOSE12.90/12.85
TODAY RANGE12.21-12.90
VOL1.07K
MARKET CAP64.05M
52 WEEK RANGE6.55-14.15
AVG VOL (3M)4.99K
% TURNOVER0.02%
TURNOVER--
P/E (TTM)31.46
% RANGE5.36%
EPS(TTM)0.4084
P/E(FORWARD)4.759
P/B1.798
BVPS7.15
DIVIDEND--
P/S528.81
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP27.74M
SHARES OUTSTANDING4.98M
NEXT EARNINGS03/04-03/12
FREE FLOAT2.16M
LOT SIZE1
EX-DATE01/05/2018
News
Press Releases
Financial Reports
Profile
TipRanks·11/25 13:05
Daxor announces expansion of its BVA platform into three new facilities
TipRanks·10/15 12:15
Daxor to exhibit at the MedAxiom CV Transforum Fall’25 Conference
TipRanks·09/30 12:25
Daxor debuts FDA-cleared BVA analyzer at HFSA meeting
TipRanks·09/23 12:15
Daxor unveils next-gen BVA analyzer at HFSA annual meeting
TipRanks·09/05 11:55
Maxim Group Remains a Buy on Daxor (DXR)
TipRanks·09/04 12:10
Daxor’s blood volume analysis validated for COVID, sepsis patients
TipRanks·09/02 12:25
Daxor reports increase in NAV to $7.15 per share
TipRanks·08/12 18:15
Daxor’s FDA Clearance and Advancements Propel Buy Rating Amidst Growth Potential
TipRanks·08/07 16:10
Morning News Wrap-Up: Thursday’s Biggest Stock Market Stories
TipRanks·08/07 12:47
Daxor Gains FDA Clearance for Blood Volume Analyzer
TipRanks·08/07 12:33
Why Is Daxor Stock (DXR) Up 20% Today?
TipRanks·08/07 12:01
Daxor receives FDA clearance for new BVA system
Benzinga·08/07 11:57
Daxor Secures FDA 510(k) Clearance For Handheld Blood Volume Analyzer
Same Industry
Name/Symbol
Change%
Price